Introduction: Defects in articular cartilage exhibit little spontaneous healing response, in part due to the limited number of chondrocytes available to infiltrate the defect and the absence of a provisional fibrin scaffold to accommodate cell migration into the lesion. One of the variables related to tissue engineering strategies employing cell-seeded scaffolds to treat such defects is the amount of cartilage that should be formed in the construct prior to its implantation. Animal studies have indicated that providing some degree of histogenesis in cell-seeded scaffolds via in vitro culture prior to implantation in chondral defects can improve repair outcomes (at 15 wks postop) compared to implantation of cell-seeded scaffolds lacking tissue formed prior to implantation (1).
The objectives of this study were to begin to test the effects of tissue-engineered cartilage implant compositional maturity (viz., glycosaminoglycan, GAG, content) on chondral defect repair in a caprine model, and to evaluate the presence of a lubricating protein, lubricin/superficial zone protein (referred to as PRG4 for the Prg4 encoding gene), in reparative tissue in the implanted and untreated defects.
Materials and Methods: Monolayer-expanded chondrocytes from 8 adult goats were seeded into type II collagen (Geistlich Biomaterials, Wolhusen, Switzerland) scaffolds and cultured in chondrogenic medium. By 2 weeks, GAG content in synthesized tissue within these constructs reached 30% of that in native caprine cartilage. Two chondral defects (to the tidemark) created in the trochlear groove of one stifle joint of each animal were implanted with the autologous chondrocyte-seeded constructs (12 defects in 6 animals), or left empty as untreated controls (4 defects in 2 animals). After 16 weeks implant sites were analyzed histomorphometrically for the type and amount of reparative tissue, and stained immunohistochemically for PRG4.
Results: Reparative tissue consisted primarily of fibrocartilage. Implantation of the tissue-engineered constructs reduced the amount of fibrous tissue formation compared to untreated controls, but did not demonstrate statistically significant effects on other outcome variables (Table 1) . PRG4 was found as a discrete layer on the surface of the reparative tissue in both implanted and untreated chondral defects (Fig. 1) , similar in appearance to its presence in the host articular cartilage (Fig. 2) . PRG4 could also be found in the extracellular matrix of the reparative tissue.
Discussion: Continuing investigations will evaluate effects of constructs with GAG contents 50% and 75% of normal cartilage on repair. Identification of PRG4 demonstrates the ability of cells within the repair tissue to synthesize this lubricating molecule, which may be of importance to the tribological function of the repair tissue.
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